Akari Therapeutics, Plc

8-K Shareholder vote results Jul 2, 2026 8-K Entered a material agreement Jun 26, 2026 8-K Entered a material agreement; Unregistered sale of equity May 22, 2026 10-Q Quarter ended 2026-03-31 May 19, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Modified rights of security holders; Regulation FD disclosure Mar 17, 2026 8-K Shareholder vote results Mar 2, 2026 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 17, 2025 8-K Shareholder vote results Dec 16, 2025 8-K Regulation FD disclosure Dec 8, 2025 8-K Delisting notice or listing-rule failure Nov 26, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Director or officer change Oct 23, 2025 8-K Entered a material agreement; Unregistered sale of equity Oct 16, 2025 8-K Regulation FD disclosure Oct 15, 2025 8-K Other events Sep 29, 2025 8-K Entered a material agreement; Other events Sep 25, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Aug 29, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Aug 21, 2025 8-K Regulation FD disclosure Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Director or officer change; Shareholder vote results Jul 1, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) Apr 16, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Director or officer change Mar 20, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 3, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Director or officer change Dec 18, 2024 8-K Director or officer change Dec 16, 2024 8-K Director or officer change Dec 12, 2024 10-Q Quarter ended 2024-09-30 Nov 19, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Delisting notice or listing-rule failure; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Nov 14, 2024 8-K Shareholder vote results; Regulation FD disclosure Nov 8, 2024 8-K Delisting notice or listing-rule failure Oct 4, 2024 8-K Director or officer change; Other events Sep 18, 2024 8-K Other events Sep 6, 2024 8-K/A Director or officer change Aug 23, 2024 10-Q Quarter ended 2024-06-30 Aug 19, 2024